TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
DNA

Ginkgo Bioworks Holdings

Healthcare · Biotechnology

7.80$ +11.0% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Ginkgo Bioworks Holdings (DNA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 90.0% of the shares are freely tradable; institutional investors hold 68.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 68.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 4.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 90.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 12.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 55Mio.

Largest Shareholders

Institutions

Institutions DNA
Name Stake (%) Shares Change (%) Date
BlackRock Inc 5.41 3,642,347 +1.9 03/31/2026
Viking Global Investors LP 5.31 3,577,128 +0.0 03/31/2026
Baillie Gifford & Co Limited. 3.55 2,391,649 +0.0 06/30/2026
Erste Asset Management GmbH 2.89 1,947,728 -2.6 03/31/2026
Vanguard Capital Management, LLC 2.84 1,914,428 +0.0 03/31/2026
Anchorage Advisors, LLC 2.59 1,746,363 +0.0 06/30/2026
Legal & General Group PLC 2.47 1,661,587 +5.3 03/31/2026

Funds

Funds DNA
Name Stake (%) Shares Change (%) Date
Scottish Mortgage Ord 3.55 2,391,649 +0.0 07/31/2026
L&G Artificial Intelligence ETF 2.42 1,632,208 +0.0 08/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.21 1,489,851 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings DNA
Person Role Shares Value As of Type
Coen Steven P. See remarks 51,851 404,438 $ Aug 24, 2026 direct
Henry Christian O Director 19,310 150,618 $ Sep 15, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 15, 2026 Henry Christian O Director Sell 5,000 7.08 35,405
Aug 24, 2026 Coen Steven P. See remarks Sell 330 6.98 2,302
Aug 21, 2026 Coen Steven P. See remarks Other 156
Aug 21, 2026 Coen Steven P. See remarks Other 587
Jul 17, 2026 Coen Steven P. See remarks Sell 752 7.90 5,943
Jul 16, 2026 Coen Steven P. See remarks Other 312
Jul 16, 2026 Coen Steven P. See remarks Other 1,174
Apr 17, 2026 Steven P Coen Insider Sell 324 7.95 2,576

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?